Abstract
Epidemiological indicators, such as reproduction numbers and epidemicity indices, describe an ongoing epidemic’s long- and short-term behaviour. Their evolving values provide context for designing control measures, as maintaining both indices below one warrants a waning epidemic. However, current models for the computation of epidemiological metrics do not consider the pathogen stratification into variants endowed with different infectivity and epidemiological severity, as was the case with SARS-CoV-2. Failing to account for such stratification prevents the resulting epidemiological indices from spotting the possible onset of uncontrolled growth of one variant within the total of new infections, thus limiting the prognostic value of the indicators. Here, we expand an existing framework for the computation of spatially explicit reproduction numbers and epidemicity indices to account for arising variants. By contrasting the data of the COVID-19 pandemic in Italy, we show that embedding additional layers of complexity in the mathematical model reveals epidemiological metrics at the emergence of new variants significantly exceeding their threshold. Such values foresee a recrudescence in new infections that only became evident after emerging variants effectively replaced the previous strains. These higher values flag the presence of a specific variant that grows more rapidly than the growth of the total number of infections generated by all variants combined. Variant-stratified epidemiological indicators do therefore allow control measures to be better tailored to the shifting severity of an ongoing epidemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
C.T. and A.R. acknowledge funding from the Swiss National Science Foundation via the project 'Optimal control of intervention strategies for waterborne disease epidemics' (grant number 200021-172578). L.M. acknowledges funding from the Italian Ministry of University and Research through the project 'Epidemiological data assimilation and optimal control for short-term forecasting and emergency management of COVID-19 in Italy' (FISR_2020IP_04249).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
All codes and data involved in this study are available at the following public GitHub repository: cristianotrevisin/epidemiological-indices-metapopulation.